|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"許駿"
Showing items 41-65 of 145 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2013 |
Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway
|
Ou, Da-Liang; Lee, Bin-Shyun; Chang, Ya-Chi; Lin, Liang-In; Liou, Jun-Yang; Hsu, Chiun; Cheng, Ann-Lii; 林亮音; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2013 |
The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines
|
Chen, Wei-Wu; Chang, Dwan-Ying; Huang, Shu-Min; Lin, Ching-Hung; Hsu, Chun; Lin, Ming-Hwai; Huang, Chiun-Shen; Lu, Yen-Shen; Cheng, Ann-Lii; 陳偉武; 盧彥伸; 鄭安理; 許駿; 黃俊升; 張端瑩; 林璟宏 |
| 國立臺灣大學 |
2013 |
Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Hsu, Chiun; Shao, Yu-Yun; Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Hsu, Chih-Hung; Yang, James Chih-Hsin; Cheng, Ann-Lii; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2013 |
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy
|
Shao, Yu-Yun; Liang, Po-Chin; Wu, Yao-Ming; Huang, Chun-Chieh; Huang, Kai-Wen; Cheng, Jason C.; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lin, Zhong-Zhe; 邵幼雲; 林宗哲; 鄭安理; 成佳憲; 黃凱文; 徐志宏; 許駿; 梁博欽; 吳耀銘 |
| 國立臺灣大學 |
2013 |
Survival of patients receiving radiofrequency ablation or ethanol injection for early-stage hepatocellular carcinoma.
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Shao, Yu Yun; Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Hsu, Chiun; Hsu, Chih-Hung; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿; 郭年真 |
| 國立臺灣大學 |
2013 |
Potential synergistic antitumor activity between sorafenib and lenalidomide in an orthotopic murine liver cancer model.
|
Chang, Chun-Jung; Ou, Da-Liang; Lin, Yi-Jang; Cheng, Ann-Lii; Hsu, Chiun; 張純榮; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2013 |
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
|
Shen, Y-C; Ou, D-L; Hsu, C.; Lin, K-L; Chang, C-Y; Lin, C-Y; Liu, S-H; Cheng, A-L; 劉興華; 鄭安理; 許駿; 歐大諒; 林靖愉 |
| 國立臺灣大學 |
2012 |
PHASE II STUDY OF CONCOMITANT THALIDOMIDE DURING RADIOTHERAPY FOR HEPATOCELLULAR CARCINOMA
|
Ch' ang, Hui-Ju; Hsu, Chiun; Chen, Chien-Hung; Chang, Ya-Hui; Chang, Jeffrey S.; Chen, Li-Tzong; 許駿; 陳健弘 |
| 國立臺灣大學 |
2012 |
Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma
|
Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chiun; Lee, Kuan-Der; Hsiao, Chi-Huang; Lu, Yen-Shen; Huang, Chien-Chung; Shen, Yin-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 盧彥伸; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu, Chiun; Yang, Tsai-Sheng; Huo, Teh-Ia; Hsieh, Ruey-Kuen; Yu, Chih-Wei; Hwang, Wei-Shou; Hsieh, Tsai-Yuan; Huang, Wen-Tsung; Chao, Yee; Meng, Robin; Cheng, Ann-Lii; 鄭安理; 許駿; 游治維 |
| 國立臺灣大學 |
2012 |
A Critical Evaluation of the Preventive Effect of Antiviral Therapy on the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C or B: A Novel Approach by Using Meta-Regression
|
Shen, Ying-Chun; Hsu, Chiun; Cheng, Chia-Chi; Hu, Fu-Chang; Cheng, Ann-Lii; 鄭安理; 許駿; 胡賦強 |
| 國立臺灣大學 |
2012 |
Factors Impacting Prognosis Prediction in BCLC Stage C and Child-Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy
|
Lin, Zhong-Zhe; Hsu, Chiun; Hu, Fu-Chang; Shao, Yu-Yun; Chang, Dwan-Ying; Yang, Chih-Hsin; Hong, Ruey-Long; Hsu, Chih-Hung; Cheng, Ann-Lii; 楊志新; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 洪瑞隆; 許駿; 胡賦強; 張端瑩 |
| 國立臺灣大學 |
2012 |
Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: a meta-analysis and meta-regression
|
Hsu, Chiun; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Yeh, Kun-Huei; 鄭安理; 許駿; 葉坤輝 |
| 國立臺灣大學 |
2012 |
Metastasectomy of Krukenberg Tumors May Be Associated with Survival Benefits in Patients with Metastatic Gastric Cancer
|
Lu, Li-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Hsu, Chun; Cheng, Wen-Fang; Lin, Yu-Lin; Cheng, Ann-Lii; Yeh, Kun-Huei; 鄭文芳; 邵幼雲; 林育麟; 鄭安理; 徐志宏; 許駿; 葉坤輝; 呂理駿 |
| 國立臺灣大學 |
2012 |
EXPLORING THE ANTI-TUMOR EFFICACY OF COMBINATION THERAPY WITH INHIBITORS TARGETING THE INSULIN-LIKE GROWTH FACTOR (IGF) AND PI3K/AKT/MTOR SIGNALING PATHWAYS FOR HEPATOCELLULAR CARCINOMA (HCC)
|
Ou, D. -L.; Hsu, C.; Lee, B. -S.; Chang, Y. -C.; Cheng, Y. -C.; Cheng, A. -L.; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2012 |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao, Y-Y; Lu, L-C; Lin, Z-Z; Hsu, C.; Shen, Y-C; Hsu, C-H; Cheng, A-L; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿; 呂理駿 |
| 國立臺灣大學 |
2012 |
THE ROLES OF GROWTH ARREST DNA DAMAGE-INDUCIBLE GENE 45 Gamma (GADD45 Gamma) EXPRESSION IN SORAFENIB-INDUCED APOPTOSIS IN HEPATOCELLULAR CARCINOMA (HCC) CELLS
|
Hsu, C.; Ou, D. -L.; Shiau, C. -W.; Fan, H. -H.; Liao, S. -C.; Lin, Y. -Y.; Hsu, C. -H.; Cheng, A. -L.; 林育誼; 鄭安理; 徐志宏; 許駿; 歐大諒 |
| 國立臺灣大學 |
2012 |
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
|
Kuo, Yu-Hsuan; Lin, Ching-Hung; Shau, Wen-Yi; Chen, Te-Jung; Yang, Shih-Hung; Huang, Shu-Min; Hsu, Chun; Lu, Yen-Shen; Cheng, Ann-Lii; 盧彥伸; 鄭安理; 許駿; 楊士弘; 林璟宏 |
| 國立臺灣大學 |
2012 |
Diabetes Mellitus Is Associated with Increased Mortality in Patients Receiving Curative Therapy for Hepatocellular Carcinoma
|
Shau, Wen-Yi; Shao, Yu-Yun; Yeh, Yi-Chun; Lin, Zhong-Zhe; Kuo, Raymond; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
THE FIRST-TWO LINES OF CHEMOTHERAPY FOR DE NOVO METASTATIC BREAST CANCER: EFFICACY STUDY BETWEEN ANTHRACYCLINES AND NON-ANTHRACYCLINES
|
Chen, W. -W.; Chang, D. -Y.; Lin, C. -H.; Hsu, C.; Cheng, A. -L.; Lu, Y. -S.; 陳偉武; 盧彥伸; 鄭安理; 許駿; 張端瑩; 林璟宏 |
| 國立臺灣大學 |
2012 |
Changes of Pulmonary Fluorodeoxyglucose Uptake After Neoadjuvant Concurrent Chemoradiation in Predicting Postoperative Pulmonary Complications for Patients With Esophageal Cancer
|
Hsu, F.; Cheng, J.; Lee, J.; Huang, P.; Hsu, C.; Lin, C.; Tsai, Y.; Tzen, K.; Yen, R.; 曾凱元; 成佳憲; 顏若芳; 蔡育傑; 許駿; 李章銘; 黃培銘; 許峰銘 |
| 國立臺灣大學 |
2012 |
CHLORHEXIDINE FOR THE PREVENTION OF BLOODSTREAM INFECTION (BSI) ASSOCIATED WITH PERMANENTLY IMPLANTABLE VENOUS PORTS (PORT-A) IN SOLID CANCER PATIENTS: A PROSPECTIVE COHORT STUDY
|
Kao, H.; Chen, I.; Chang, S.; Hong, M.; Chien, S.; Hu, F.; Hsu, C.; Yeh, K.; 許駿 |
| 國立臺灣大學 |
2012 |
CYCLIN E1 SUPPRESSION CONTRIBUTES TO SORAFENIB-INDUCED APOPTOSIS IN HEPATOCELLULAR CARCINOMA (HCC)
|
Hsu, C.; Ou, D.; Cheng, Y.; Lin, Y.; Chang, Y.; Yeh, K.; Cheng, A.; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2011 |
Activation of Checkpoint Kinase 2 (Chk2) Contributes to the Antitumour Synergy between Igf1 Receptor Kinase Inhibitor Nvp-Aew541 and Sunitinib in Hepatocellular Carcinoma
|
歐大諒; 沈盈君; 許駿; 鄭安理; OU, DA-LIANG; SHEN, YING-CHUN; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2010-07 |
多向度問卷之設計、翻譯與測試
|
季瑋珠; 許駿; 章殷超; 程劭儀; 高芷華 |
Showing items 41-65 of 145 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page
|
